Clinical Trials Logo

Dyskinesias clinical trials

View clinical trials related to Dyskinesias.

Filter by:

NCT ID: NCT05516875 Not yet recruiting - Dyskinesias Clinical Trials

Open-Label Extension Study of ASTORIA

Start date: January 31, 2023
Phase: Phase 2
Study type: Interventional

This current open-label extension (OLE) study (JM-010CS-OL) will explore the safety and tolerability of long-term administration of JM-010 of patients who completed 12-week treatment of Phase 2 (JM-010CS03) study.

NCT ID: NCT05516693 Recruiting - Swallowing Disorder Clinical Trials

Chewing, Swallowing and Orofacial Motricity in Severe Obese

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Background: Obesity is considered an epidemic disease of great repercussion on the world and its prevalence has increased in recent decades. The treatment of obesity aims to improve health and quality of life, by reducing body weight. The clinical approach to obesity is routinely the first line of treatment. Clinical treatment usually involves a combination of restriction of caloric intake, modification of behavior and habits, regular practice of physical activity and pharmacotherapy. Clinical treatment of obesity leads to considerable weight loss, but often not sustained in most patients. This long-term sustained weight loss is an attribute of bariatric surgery, since severe obesity remains largely refractory to dietary and drug therapy. Changes in lifestyle that occur in severely obese patients undergoing bariatric surgery, especially in terms of food, lead to the need for the contribution of speech therapy to adapt to the new way of ingesting food. Objectives: to analyze the stomatognathic functions of mastication and swallowing and to verify the effectiveness of orofacial motricity stimulation in adults, severely obese before and after bariatric surgery. Methods: This is a randomized, controlled clinical trial involving severely obese adult patients of both sexes referred for bariatric surgery. This study was approved by the Research Ethics Committee of the Centro Universitário Fundação Assis Gurgacz (FAG) in the city of Cascavel (PR), Brazil, protocol number CEP FAG no. 4,169,295. Patients will be consecutively recruited from the Bariatric Surgery Department of Hospital São Lucas (FAG) and referred to the Speech Therapy Clinic according to the eligibility criteria of the research protocol. After the initial assessment, patients will be randomly assigned to an intervention group (MOG) and a control group (COG). The COG and MOG groups will be evaluated before and after bariatric surgery. Only the GMO will be submitted to the speech therapy training program before bariatric surgery. The myofunctional characteristics will be evaluated through the Orofacial Myofunctional Assessment protocol with Scores (AMIOFE). The AMIOFE protocol was designed according to the assessment models that reflect the physical characteristics and orofacial behaviors of individuals. In this way, the components and functions of the stomatognathic system will be evaluated in terms of appearance/posture, mobility and swallowing functions - liquid and solid - chewing and breathing.

NCT ID: NCT05500131 Completed - Knee Injuries Clinical Trials

The Association Between Restricted Ankle Joint Dorsiflexion and Dynamic Knee Valgus

TOBROD
Start date: October 1, 2018
Phase:
Study type: Observational

The purpose of this study was to analyze if a low ankle dorsiflexion range is associate with dynamic knee valgus in youth basketball players.

NCT ID: NCT05435729 Completed - Parkinson's Disease Clinical Trials

A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

Start date: May 31, 2022
Phase: Phase 1
Study type: Interventional

This study is an open-label of single transdermal dose of DSP-9632P to evaluate the dopamine release derived from levodopa in brain, and a randomized, double-blind, placebo-controlled, 2-way crossover of multiple transdermal doses of DSP-9632P to evaluate the safety and tolerability in patients with levodopa-induced dyskinesia in Parkinson's disease.

NCT ID: NCT05426694 Recruiting - Scapular Dyskinesis Clinical Trials

Effectiveness of Scapular Clock Exercises in Scapular Dyskinesia in Post-Operative Open Heart Surgery Patients

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

In patients after open-heart surgery, the complaint of scapular dyskinesia is very common. It occurs due to the weakness of the muscles surrounding the scapula. In this research, investigators checked the effectiveness of scapular clock exercises in scapular dyskinesia, in post-op open heart surgery patients. There were two groups, an intervention "Active group" and a 'control group'. The patients will be randomly assigned to each group equally. The treatment session was given for a period of 4 weeks, with 3 sessions each week. They were assessed before treatment, after 2 weeks and post-intervention.

NCT ID: NCT05424185 Not yet recruiting - Scapular Dyskinesis Clinical Trials

Rate of EMG Rise and Rate of Force Development of Scapular Muscles

Start date: July 1, 2022
Phase:
Study type: Observational

The investigators will clarify rate of electromyography (EMG) rise and rate of force development in overhead athletes on scapular muscles, including upper trapezius, lower trapezius and serratus anterior. The correlation between rate of EMG rise and rate of force development will also be examined.

NCT ID: NCT05374720 Recruiting - Hysterectomy Clinical Trials

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

CILTUBE
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women

NCT ID: NCT05317390 Recruiting - Parkinson Disease Clinical Trials

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

NCT ID: NCT05297201 Recruiting - Parkinson Disease Clinical Trials

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia

Start date: November 2, 2021
Phase: Phase 2
Study type: Interventional

The aim of the study is to determine potential anti-dyskinetic properties of CPL500036 (PDE10A inhibitor) in Parkinson disease patients suffering from levodopa Induced dyskinesia. The study is to determine the efficacy and dose response of two CPL500036 doses, compared with placebo.

NCT ID: NCT05287022 Recruiting - Clinical trials for Primary Ciliary Dyskinesia

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Start date: June 14, 2021
Phase:
Study type: Observational

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.